NMD Pharma AS

“We’re at an exciting juncture in medicine where the perceived scientific boundaries in treatment across therapeutic areas continue to dissolve.” These words from Jeffrey Jones , chief medical office

Gilde Healthcare, a venture capital and private equity firm with more than €2.5bn in invested capital, closed its Gilde Healthcare Venture&Growth VI Fund with €740m ($806.5m) in commitments, building

Venture capital investors showed biopharmaceutical start-ups and growth-stage private companies some love with a trio of $100m-plus financings announced on 14 and 16 February, including a $236m series

There are several high-profile examples of biotech leaders who have seeded, nurtured and grown their companies into profitable, sustainable organisations. Josh Boger founded Vertex Pharmaceuticals In